The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Amnioinfusion in treatment of oligohydramnios in women with preterm pregnancy
Author(s): 
Pages: 834-838
Year: Issue:  12
Journal: New Chinese Medicine

Keyword:  AmnioinfusionOligohydramniosPreterm pregnancy;
Abstract: Objective To evaluate the clinical efficacy and safety of amnioinfusion in the treatment of oligohydramnios for women with preterm pregnancy. Methods Ninety eight preterm pregnancy patients di-agnosed with oligohydramnios were collected in this investigation. In the observation group,48 patients re-ceived amnioinfusion,and the remaining 50 patients received intravenous fluid infusion in the control group.The pregnant outcomes,variation of amniotic fluid index,prolonged gestational age and neonatal outcomes were statistically compared between two groups. Results Compared with the control group,the percentage of trans-vaginal natural birth,variation of amniotic fluid index upon the completion of treatment and one week after treatment,prolonged gestational age,the percentage of childbirth in women with over 35-week pregnancy and neonatal weight were significantly improved (all P<0.05 ),whereas the percentage of newborns transferred to NICU was considerably decreased in the observation group (all P<0.05 ). The detection rate of fetal abnor-mality,the percentage of live birth,premature rupture of membrane,amniotic fluid turbidity and the percent-age of neonatal asphyxia did not significantly differ between two groups (all P>0.05 ). Conclusions Am-nioinfusion is a safe treatment of oligohydramnios in preterm pregnancy women,which can significantly increase the amniotic fluid index and prolong the gestational age.
Related Articles
No related articles found